arcoris bio

What arcoris bio does

arcoris bio AG is a Swiss life science tools company founded in 2022 in Schlieren, Switzerland, that develops and commercializes MUSE® (Multiplex Universal Signal Enhancement), an enzyme-free self-assembling DNA nanotechnology platform for biomarker detection and signal amplification. The technology uses a patented key-and-lock molecular mechanism to assemble hyperbranched polymers that attach fluorophores, chromogenic enzymes, or metal contrast agents to probe-ligand complexes, enabling real simultaneous multiplex imaging (1-plex to 7-plex) of proteins, DNA, and RNA in a two-step, room-temperature workflow that requires no specialized equipment and delivers same-day results. The company monetizes through three channels: (1) off-the-shelf immunoMUSE® Activate & Amplify kits sold in 1-plex, 2-plex, and 4-plex formats with multiple fluorophore options via the company website; (2) custom reagent solutions covering RNA detection (rnaMUSE®), combined IF+FISH, extended 7-plex multiplexing, and alternative readouts; and (3) licensing and technology integration arrangements with antibody, assay, and instrument partners including white-label and private-label options. The company serves academic and biopharma cancer research labs, immunology and neuroscience research groups, and life science tools/diagnostics companies, with named academic reference users at the University of Lausanne and the University of Geneva. As of November 2025, the company had raised CHF 6.3 million in an oversubscribed seed round co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher Kantonalbank and private investors, to industrialize the platform and expand strategic partnerships.

Name

arcoris bio

Legal name

arcoris bio AG

Website

https://arcorisbio.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

arcoris bio is a Swiss life science tools company founded in 2022 that develops MUSE®, an enzyme-free DNA nanotechnology platform enabling high-sensitivity, room-temperature multiplex detection of proteins, DNA, and RNA, commercialized through immunoMUSE® kits, custom solutions, and licensing for academic, biopharma, and diagnostics customers.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Multiplex biomarker detection
• Spatial multiomics solutions
• Signal amplification technology
• Immunofluorescence research kits
• DNA nanotechnology platform

Headquarters

HQ city

Schlieren

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. immunoMUSE® Kit Sales: Sale of off-the-shelf immunoMUSE® Activate & Amplify kits in various sizes (Small 5 reactions, Medium 25 reactions, Large 50 reactions) and plex formats (1-plex, 2-plex, 4-plex). Kits include conjugation reagents and amplification reagents.
2. Custom Solutions: Custom reagent solutions for applications beyond standard kits, including RNA detection, combined IF and FISH (rnaMUSE®), extended multiplexing up to 7-plex, and alternative readouts (fluorophores, enzymes, metal labels). Custom antibody conjugation services available.
3. Licensing and Technology Integration: Licensing of MUSE® technology to commercial partners for integration into their antibody portfolios, assay platforms, or instrument solutions. Includes white-label and private-label options for B2B partners.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels10 records

Core offering

arcoris bio develops and sells MUSE® (Multiplex Universal Signal Enhancement), an enzyme-free self-assembling DNA nanotechnology platform that drives signal amplification for biomarker detection across proteins, DNA, and RNA. The company commercializes this platform through off-the-shelf immunoMUSE® Activate & Amplify kits for multiplex immunofluorescence, custom reagent solutions for RNA and combined IF/FISH workflows, and licensing of the technology to life science tools and diagnostics partners.

Product overview

arcoris bio offers a platform-plus-modules architecture centered on the MUSE® (Multiplex Universal Signal Enhancement) technology. MUSE® is an enzyme-free DNA nanotechnology platform that provides universal, programmable signal amplification for highly sensitive multiplex biomarker detection. The product portfolio consists of: (1) MUSE® as the core technology enabling detection of proteins and nucleic acids from 1-plex to 7-plex; (2) immunoMUSE® Activate & Amplify kits as off-the-shelf solutions for immunofluorescence with 1-plex, 2-plex, and 4-plex options; (3) Custom MUSE® solutions extending to RNA detection, combined IF+FISH, and specialized applications; and (4) Licensing/technology integration services for partners. All products work in a two-step, room-temperature workflow with same-day results and no specialized equipment required.

Differentiator

Problem solved

Functional benefit

Brands

• MUSE®: Multiplex Universal Signal Enhancement - enzyme-free DNA nanotechnology platform for biomarker detection and signal amplification
• immunoMUSE®
• rnaMUSE®

Products and services

• immunoMUSE® Activate & Amplify kits Off-the-shelf ready-to-use kits for high-sensitivity multiplex immunofluorescence. Researchers conjugate their own BSA/azide-free primary antibodies to MUSE® activators and run 1-plex, 2-plex, or 4-plex panels with fluorophores at 488nm, 565nm, 647nm, and 750nm. No species or isotype constraints; intended for academic and biopharma research labs working on cancer, immunology, and neuroscience tissue samples.
• immunoMUSE® Amplify kits Standalone amplification reagent kits for scaling multiplex immunofluorescence workflows. Available in Medium (25 reactions) and Large (50 reactions) sizes with 1-plex, 2-plex, and 4-plex formats, used to expand experiments beyond the initial Activate kit conjugation.
• Custom MUSE® solutions Tailored reagent solutions extending MUSE® beyond standard kits. Covers rnaMUSE® for RNA detection, combined IF + FISH (rnaMUSE® + immunoMUSE®), multiplexing up to 7-plex, and applications in IHC, ISH, IMC, FACS, and LFA with alternative readouts (fluorophores, HRP enzyme, or metal ions). Custom antibody conjugation services available.
• MUSE® licensing and technology integration Licensing offering that lets antibody providers, assay manufacturers, instrument companies, and distributors integrate MUSE® signal amplification into their own products. Includes private-label and white-label options, co-branded kit development, and full workflow integration support for life-science tools, in vitro diagnostics, and pharma services partners.

Quantifiable outcome

• Detects low-abundance biomarkers including HER2-low and HER2-ultralow expression states relevant to treatment eligibility
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Three partnerships are on record, tiered potential partner.

• Antibody & Assay Portfolio Companiespotential partnerTechnology or IntegrationCompanies with existing antibody portfolios can integrate MUSE® technology to enhance current assays and create new products. The platform is positioned as flexible across multiple assay types including IHC, IF, FISH, FACS, ELISA, and LFA.
• Instrument Companiespotential partnerTechnology or IntegrationInstrument manufacturers can integrate MUSE® as a high-performance, scalable reagent solution for biomarker detection. MUSE® works at room temperature in aqueous solutions making it ideal for automation and instrument integration.
• Life Science Tools Distributorspotential partnerChannel Partner/ Reseller/ DistributorDistributors and resellers can offer MUSE®-based products to their customer bases. Flexible private/white-label options available for partners wanting to integrate technology under their own brands.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Standard BioTools (formerly Fluidigm): Standard BioTools offers Hyperion imaging mass cytometry (IMC) for highly multiplexed tissue imaging; the company is one of the named compatible assay formats for MUSE® and a direct competitor for high-plex biomarker detection in research labs.
• Akoya Biosciences: Akoya's PhenoCycler (formerly CODEX) and Opal multiplex immunofluorescence platforms are the closest direct competitors to arcoris bio's immunoMUSE® kits, serving the same oncology, immunology, and spatial biology researchers with multiplex IF workflows on FFPE tissue.
• Lunaphore: Lunaphore's COMET platform provides automated, sequential multiplex immunofluorescence staining and is highly comparable to MUSE®'s value proposition of simplified, high-sensitivity multiplex IF for translational and clinical research customers.

Broad incumbents

• 10x Genomics: 10x Genomics' Visium and Xenium spatial omics platforms define the spatial biology category in which arcoris bio competes; while broader and more expensive, they compete for the same translational research and pharma spatial profiling budget.
• Cell Signaling Technology: CST is a leading provider of validated antibodies and IHC/IF reagents; it competes with arcoris bio for primary-antibody-driven research budgets and is a candidate licensing/white-label partner for MUSE® activators.
• Miltenyi Biotec: Miltenyi offers MACSplex multiplex bead-based assays, flow cytometry reagents, and imaging products that intersect with MUSE®'s reagent and FACS-compatible positioning across immunology and translational research.
• Bio-Techne: Bio-Techne's ProteinSimple and reagents division offers multiplex western blot, single-cell, and spatial biology reagents, overlapping with MUSE®'s reagent and licensing opportunity across academic and pharma customers.
• Abcam: Abcam is one of the largest antibody and reagent suppliers globally and an obvious licensing/white-label candidate for MUSE® activators; its recombinant antibody portfolio overlaps with immunoMUSE®'s open primary-antibody workflow.
• NanoString Technologies (a Bruker company): NanoString's GeoMx digital spatial profiling and CosMx spatial molecular imager compete for the same translational research spend in immuno-oncology and tumor microenvironment profiling that MUSE® targets.

Emerging players

• IonPath (Bruker Spatial Biology): IonPath's MIBI (multiplexed ion beam imaging) platform provides high-plex spatial proteomics and competes for translational research and pharma biomarker discovery budgets that MUSE® also targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arcoris-bio-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about arcoris bio